Search

everythinglearnresearchcommunity

for

Search:↓

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Entadfi, a mix of finasteride and tadalafil, is used for BPH.

KY19382 helps to regrow hair and create new hair follicles.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

UTX is crucial for skin differentiation and health, especially in females.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Lamotrigine can cause hair loss in some patients.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

The dog's skin infection was cured with a new antibiotic treatment and supplements.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.

Axitinib treatment turned a man's grey hair back to black.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Belimumab effectively controls SLE disease activity and reduces steroid use.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.